|
A
new clinical trial is looking into this possibility using a
new classification of drug called an aromatase inhibitor.
This medication has already been used with women who
have breast cancer and has been shown to be more effective and
safer than other products currently being used.
The next step is to see if it can be used to prevent
breast cancer in HIGH
RISK WOMEN.
Who
can participate?
Who is
at high risk?
To
learn more about this exciting new study call:
Debra
Wells, CNP
MedStar Research Institute
650 Pennsylvania Ave., SE Suite 50
Washington, DC 20003
(202)
787-5710
|